New Standard of Care for Diabetic Macular Edema?
June 11, 2010
Submit Comments
In this month’s Archives, a regimen of ranibizumab plus laser generated superior results over laser alone. There was a five letter difference. It would now seem that we ought to offer this regimen, even though I am sure plenty of patients may prefer to avoid the injections and stick with laser alone.
You might also enjoy...
- Ranibizumab With Prompt/Deferred Laser Or Alone Again Beats Laser
- Is Lucentis (ranibizumab) Effective in Treating CRVO?
- Is Ranibizumab Plus Laser Superior to Laser or Injections Alone for Diabetic Edema?
- PrONTO Study Year 2: Evaluating a Variable-dosing Regimen with Intravitreal Lucentis (ranibizumab)
- Is Ranibizumab Superior to Laser for DME?
Comments
Jump down to form below to submit your own comments
